can semaglutide cause eye problems Understanding and Its Impact on Vision Wegovy linked to rare “eye

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

2021;7(1): e12158

Sabu et al

Once dysphagia is confirmed, the phase decides the code: No phase documented goes to R13.10 Oral phase goes to R13.11 Oropharyngeal phase goes to R13.12 Pharyngeal phase goes to R13.13 Pharyngoesophageal phase goes to R13.14 A documented phase that doesn't fit the above goes to R13.19 Update After the Study: When an MBSS or FEES names the phase after you started with R13.10, move to the specific code for the next claims